Where I'd Invest for Value in Canadian Stocks During This Market Correction
Written by Jitendra Parashar at The Motley Fool Canada
It's true that market corrections can be uncomfortable. But for value-focused investors, such corrections tend to bring some of the best opportunities. Right now, with the TSX struggling to hold ground in early 2025 amid worries about trade tensions and inflation weighing on sentiment, many great Canadian stocks are trading at rare discounts.
That's why it could be the right time to focus on quality companies whose long-term prospects haven't changed much, even if their share prices have taken a temporary hit. Let's take a closer look at two such fundamentally strong value stocks listed on the Toronto Stock Exchange.
Down 50% over the last 12 months, BRP (TSX:DOO) is the first value stock I'd be looking at during this market correction. This Valcourt-based firm focuses on making recreational vehicles and powersports products. Right now, BRP stock is trading at around $46.69 per share, giving it a market cap of about $3.4 billion. On top of that, it offers a 1.8% annualized dividend yield, which can be a nice bonus for income seekers.
A broader slowdown in recreational vehicle demand could be one of the key reasons behind DOO stock's recent declines. BRP's revenues slipped by nearly 20% YoY (year over year) in the January 2025 quarter because of weaker demand and the company's strategy to trim network inventory. In addition, its normalized EBITDA (earnings before interest, taxes, depreciation, and amortization) fell by about 45% from a year ago, partly due to lower shipment volumes and higher promotional spending.
But despite these short-term challenges, BRP is continuing to focus smartly on the future. For example, in recent quarters, the company trimmed dealer inventories faster than competitors to protect brand value, even if it meant sacrificing some short-term sales. It's also leaning hard into its powersports core business while scaling back its marine operations, which could sharpen its focus and growth prospects down the line.
Overall, with a strong product lineup and innovation plans in motion, BRP looks like a classic case of a temporarily beaten-down stock with strong rebound potential once the market stabilizes.
Another top-value stock catching my eye during this correction is Magna International (TSX:MG). This global mobility technology giant is known for building everything from auto body parts and advanced driver assistance systems to complete vehicles. Right now, MG stock trades around $47.38 per share with a market cap of about $13.4 billion. Besides, it offers an attractive annualized dividend yield of nearly 5.9%.
Over the past year, the stock has slipped nearly 29%, mainly reflecting industry-wide challenges and lower vehicle volumes in its key markets. However, in the fourth quarter of 2024, the company's sales still managed to grow 2% YoY to US$10.6 billion, supported by new program launches and stronger engineering revenues. Similarly, smart operational execution helped it post a strong 27% YoY increase in its adjusted quarterly earnings to $1.69 per share.
Moreover, Magna is increasing its focus on expanding its margins, boosting cash flow, and even trimming capital spending to keep things efficient. With its 2026 sales and earnings projected to climb, Magna could see a quick bounce back once market sentiment improves.
The post Where I'd Invest for Value in Canadian Stocks During This Market Correction appeared first on The Motley Fool Canada.
Before you buy stock in Brp Inc., consider this:
The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and Brp Inc. wasn't one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years.
Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the 'eBay of Latin America' at the time of our recommendation, you'd have $21,345.77!*
Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 24 percentage points since 2013*.
See the Top Stocks * Returns as of 4/21/25
More reading
Made in Canada: 5 Homegrown Stocks Ready for the 'Buy Local' Revolution [PREMIUM PICKS]
Market Volatility Toolkit
Best Canadian Stocks to Buy in 2025
Beginner Investors: 4 Top Canadian Stocks to Buy for 2025
5 Years From Now, You'll Probably Wish You Grabbed These Stocks
Subscribe to Motley Fool Canada on YouTube
Fool contributor Jitendra Parashar has positions in Magna International. The Motley Fool recommends Brp and Magna International. The Motley Fool has a disclosure policy.
2025
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
26 minutes ago
- Yahoo
Starmer to visit Canada amid Trump threats
Sir Keir Starmer will visit Canada for security talks next week amid Donald Trump's threats to annex the country. The Prime Minister will meet Mark Carney, his Canadian counterpart, on June 14 for discussions concerning security and economic co-operation, according to The Times. It comes after the US president warned that he was prepared to wreck the Canadian economy in an attempt to force it to become the 51st US state. Mr Trump has already doubled tariffs on steel imports to 50 per cent, piling pressure on Ottawa following a meeting with Mr Carney in Washington. Fears have been raised of 'catastrophic' job losses, factory closures and disruption to supply chains in Canada in the wake of the tariffs. The UK is exempt from the 50 per cent tariff following a deal between London and Washington. But the US president, in a post on Truth Social, said there would be financial consequences of Canada remaining independent. He said the country would be faced with the $61 billion (£49 billion) cost of being covered by his proposed Golden Dome missile defence system. However, he added it would be 'zero dollars if they become our cherished 51st State'. The post was written hours after King Charles opened the 45th Canadian Parliament in May. During his speech the King underlined the Commonwealth country's sovereignty in 'dangerous and uncertain' times. Mr Carney told the Canadian broadcaster CBC he wished to join ReArm Europe, a plan designed to beef up European defence, in a drive to make Canada less reliant upon the US. The EU has also indicated it is looking to forge stronger ties with Canada given its links to Nato and the level of support it is offering to Ukraine. Mr Carney said: 'Seventy-five cents of every [Canadian] dollar of capital spending for defence goes to the United States. That's not smart.' The Canadian prime minister, in an interview with Sky News last month, was highly critical of Mr Starmer's decision to offer the US president a second state visit to the UK as the move had sparked fury in Canada. 'To be frank, we weren't impressed by that gesture … given the circumstance. It was at a time when we were being quite clear about the issues around sovereignty.' He made clear that the invitation for the King – Canada's head of state – to be in attendance at the opening of Parliament in Ottawa was 'not coincidental'. Sir Keir, who is yet to meet the former Bank of England governor since he won the Canadian election in April, wished to hold talks with Mr Carney due to them both being centre-left leaders within the G7. Number 10 has declined to comment. Broaden your horizons with award-winning British journalism. Try The Telegraph free for 1 month with unlimited access to our award-winning website, exclusive app, money-saving offers and more.
Yahoo
an hour ago
- Yahoo
SOLVE FSHD and Modalis Announce Strategic Collaboration to Develop an Innovative CRISPR-Based Epigenome Editing Treatment for Facioscapulohumeral Muscular Dystrophy
VANCOUVER, British Columbia & TOKYO & WALTHAM, Mass., June 08, 2025--(BUSINESS WIRE)--SOLVE FSHD, a venture philanthropy organization dedicated to accelerating treatments for facioscapulohumeral muscular dystrophy (FSHD), and Modalis Therapeutics Corporation (TSE 4883; "Modalis"), a CRISPR-based epigenome editing therapeutics company focused on rare genetic diseases, today announced a strategic collaboration to develop an innovative therapy for FSHD, a debilitating muscular disorder affecting approximately 1 million individuals worldwide. The novel therapy leverages Modalis's proprietary CRISPR-GNDM® (Guide Nucleotide-Directed Modulation) technology, which can dynamically modulate gene expression without introducing double-strand DNA breaks. SOLVE FSHD will provide strategic funding to support the development of Modalis's MDL-103 program. MDL-103 is an innovative therapeutic solution that continuously suppresses the expression of the DUX4 gene, the toxic disease-causing gene for FSHD, which becomes abnormally activated due to epigenetic changes in the D4Z4 repeat region on chromosome 4. MDL-103 is designed to have durable activity over long periods of time under the control of a strong, muscle-specific promoter, and is delivered to the muscles of patients using a muscle-tropic AAV delivery system. Modalis's CRISPR-GNDM® technology has the potential to transform the treatment of FSHD by epigenetically silencing the expression of DUX4. "SOLVE FSHD is pleased to partner with Modalis and to add them to our diverse portfolio of collaborators that are advancing potential therapies for FSHD," stated Eva Chin, Executive Director of SOLVE FSHD. "SOLVE FSHD identified Modalis as a company committed to finding a cure for this debilitating condition. We were impressed by their unique approach to targeting the epigenetic cause of FSHD, using a platform technology that has shown promise in other neuromuscular diseases. We believe that the support from SOLVE FSHD will allow Modalis to accelerate the advancement of MDL-103 into clinical trials." "We are delighted to be working in partnership with SOLVE FSHD and greatly appreciate the invaluable support for the development of MDL-103," said Haru Morita, CEO of Modalis. "This strategic collaboration is a strong validation of Modalis's CRISPR-GNDM® technology and our MDL-103 program. As a pioneer in this technology, we have demonstrated promising long-term drug efficacy in mouse models, shown durable target engagement and safety in non-human primates, and exhibited excellent biodistribution in neuromuscular disorders. We believe that MDL-103, which incorporates CRISPR-GNDM® technology with a muscle tropic AAV delivery system, has significant potential as a breakthrough treatment for FSHD." About SOLVE FSHD SOLVE FSHD is a venture philanthropic organization established to catalyze innovation and accelerate key research in finding a cure for FSHD. Established by renowned Canadian entrepreneur and philanthropist, Chip Wilson, the Wilson family has committed $100 million to kick-start funding into projects that support the organizations' mission to solve FSHD by 2027. The goal of SOLVE FSHD is to find a solution that can slow down or stop muscle degeneration, increase muscle regeneration and strength, and improve the quality of life for those living with FSHD, visit About Modalis Therapeutics Corporation Modalis was founded in 2016 and conducts research and development activities in Massachusetts, USA. Modalis is a pioneering leader in the field of epigenetic medicine. Modalis develops therapeutics for patients suffering from serious genetic disorders such as neuromuscular diseases, CNS diseases, and cardiomyopathies. Modalis's proprietary CRISPR-GNDM® technology is capable of specifically up or down modulating the expression of disease-relevant genes without introducing double-strand DNA breaks. For more information, visit View source version on Contacts SOLVE FSHDAlexandra Grant, House of Wilsonalexandrag@ Modalis Therapeutics CorporationCorporate Planning Departmentmedia@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Hamilton Spectator
an hour ago
- Hamilton Spectator
U.S. ambassador says Canadians facing device searches, detainment ‘not a pattern'
OTTAWA - The American ambassador to Canada is pushing back on Ottawa's travel advice, saying his country doesn't search phones at the border and arguing some Americans travelling here are having a tough time. 'We welcome Canadians to come in and invest, to spend their hard-earned Canadian dollars at U.S. businesses,' U.S. Ambassador Pete Hoekstra told The Canadian Press in an interview Friday. 'If a Canadian has had a disappointing experience coming into the United States, I'm not denying that it happened, but I'm saying it's an isolated event and it is not a pattern.' In April, Ottawa updated its advice to Canadians travelling to the United States to warn them about the possibility they might be detained if denied entry. 'Expect scrutiny at ports of entry, including of electronic devices,' reads the new guidance. There have been reports of Canadians facing intensified scrutiny at the border, having phones searched and, in some cases, being detained. Hoekstra insisted concerns about device searches are not grounded in reality. 'Coming to the U.S., that's a decision for the Canadians to make. Searching devices and all of that is not a well-founded fear. We don't do that. America is a welcoming place,' he said. He said some Americans have expressed similar concerns about Canada. 'I've heard that from Americans coming into Canada as well, OK? Saying, 'You know, we've not received a warm reception when we've gotten to Canadian customs,'' he said. When asked if these reports from American travellers involve arbitrary phone searches and lengthy detainment, Hoekstra said there are consular cases of Americans complaining to the embassy about the Canada Border Services Agency. 'We've said, 'OK this may have been an isolated event. There may have been a Canadian border person who was having a bad day, and thought they'd take it out on, you know, somebody across the border,'' he said. In a statement, the CBSA said its officers follow a code of conduct and the federal ethics code that both require them to treat everyone equally, and the agency investigates any complaints of mistreatment. 'Employees are expected to conduct themselves in a way that upholds the values of integrity, respect and professionalism at all times,' wrote spokeswoman Karine Martel. 'Treating people with respect, dignity and fairness is fundamental to our border services officers' relationship with the public and a key part of this is serving all travellers in a non-discriminatory way.' Hoekstra said travel to the U.S. is up to individuals. 'If you decide that you're not going to come down or whatever, that's your decision and you're missing an opportunity. There are great things to see in America,' Hoekstra said. He also noted the case of CNN journalist Christiane Amanpour, who recently said she prepared to visit the U.S. last month as if she was 'going to North Korea' — with a 'burner phone' that didn't carry any personal information — only to experience a warm welcome. 'It's like, (let's) get past the rhetoric and let's look at the real experiences that people are having here,' Hoekstra said. Airlines have been cutting flights between Canada and the U.S. due to a slump in demand, and Flight Centre Travel Group Canada reported a nearly 40 per cent drop in flights between the two countries year-over-year in February. A survey in early May conducted by Leger Marketing for the Association for Canadian Studies found 52 per cent of respondents feel that 'it is no longer safe for all Canadians travelling to the United States,' with 29 per cent disagreeing and 19 per cent saying they were unsure. Roughly the same proportion said they personally feel unwelcome in the U.S. LGBTQ+ groups have opted against attending World Pride events in Washington and United Nations events in New York, citing scrutiny at the border as the Trump administration scales back protections for transgender and nonbinary people. This report by The Canadian Press was first published June 7, 2025.
